Skip to Content

Health

Vaping marijuana by teens doubles in last seven years, with potentially harmful consequences, study says

By Sandee LaMotte, CNN Marijuana vaping by school-aged youth doubled between 2013 and 2020, a new study found, with reported use within the last 30 days rising seven-fold during the same time period. The study, published Monday in JAMA Pediatrics, analyzed 17 studies conducted throughout Canada and the United States that involved nearly 200,000 adolescents.

Continue Reading

Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11

By Jamie Gumbrecht, CNN Interim results of a Phase 2/3 trial showed Moderna’s Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday. The trial included more than 4,700 participants between the ages of 6 and 11, and looked at two 50-microgram doses of Moderna’s

Continue Reading

Covid chaos grips the East and uncertainty haunts the West. Europe is entering its second pandemic winter

By Tara John, CNN Lockdowns, spiraling cases and a vaccine divide is framing the start of Europe’s second pandemic winter, bringing chaos to eastern European countries and uncertainty to those in the West. Despite the widescale availability of vaccines this winter compared to the last, Europe is the only part of the world reporting an

Continue Reading

FDA vaccine advisers vote to recommend Pfizer’s Covid-19 vaccine for children 5 to 11

By Maggie Fox, CNN Vaccine advisers to the US Food and Drug Administration voted 17-0 with one abstention Tuesday to recommend emergency use authorization of Pfizer’s Covid-19 vaccine in children ages 5 to 11. Members of the FDA’s Vaccines and Related Biological Products Advisory Committee agreed the benefits of vaccinating younger children appeared to outweigh

Continue Reading

CDC updates health warning for aromatherapy spray

By Maggie Fox, CNN Federal agencies updated recalls and warnings to doctors Wednesday about aromatherapy sprays that have been linked to fatal cases of a rare tropical disease. The US Centers for Disease Control and Prevention said doctors should be on the lookout for symptoms of melioidosis — a difficult-to-diagnose infection caused by the bacteria

Continue Reading

Lemon Baked Cod With Pistachio Crust

By Michelle Dudash, CNN This 30-minute recipe is light and satisfying, offering a nice crunch from the pistachios. This flavor profile would also work great on other seafoods available, like salmon, trout and tilapia. My husband’s must-have accompaniment with most seafood dishes is tartar sauce. And his is the best! If you have a bit

Continue Reading

Greek 7-Layer Hummus Dip

By Michelle Dudash, CNN This savory dip is a crowd-pleaser. I served this to my gaggle of girlfriends for a pre-dinner wine and snack meet-up during an active tennis vacation, and it was so easy to throw together while feeling oh-so Mediterranean, fresh, healthy and light. 1 pan + 9 women = gone. Serve with

Continue Reading

Brain fog in Covid-19 patients can persist for months, even in those who were not hospitalized, study finds

By Jacqueline Howard, CNN Cognitive impairment — described as brain fog — can persist for months in Covid-19 patients, even for some who were not hospitalized, according to a new study. The research, published Friday in the journal JAMA Network Open, found that nearly a quarter of Covid-19 patients in a Mount Sinai Health System

Continue Reading

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine

By Maggie Fox, CNN US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed recommendations for booster doses for Moderna’s and Johnson & Johnson’s coronavirus vaccines Thursday, allowing millions more Americans to begin getting booster shots. Walensky also endorsed the mix-and-match approach to boosters, saying eligible people could choose whichever vaccine they wished

Continue Reading

Booster dose of Pfizer/BioNTech coronavirus vaccine shows 95.6% efficacy in Phase 3 trial, companies say

By Jacqueline Howard, CNN A booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — against Covid-19 in a Phase 3 trial, the companies announced on Thursday. They noted that “efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions.” The trial included more than 10,000

Continue Reading

5 expert tips to stress less this fall

By Sandee LaMotte, CNN As we head into what was supposed to be the fall recovery, the world is still reeling from Covid-related anxiety. It shows up in tepid job recovery and stock market tremors as well as in disagreements over masks and vaccine requirements in our schools and communities. It’s not just Covid–19 that’s

Continue Reading

More people are getting boosters than new Covid-19 vaccinations. And others could soon become eligible for an additional shot

By Madeline Holcombe, CNN The number of people in the US looking to boost their Covid-19 vaccinations has surpassed the tally of those looking to begin them as booster doses from more drug makers may soon be available. There are 1.3 times as many boosters administered each day compared with first shots, data from the

Continue Reading

Pfizer vaccine is 93% effective in preventing COVID-19 hospitalization among adolescents, CDC study finds

The Pfizer/BioNTech vaccine is 93% effective in preventing hospitalization due to COVID-19 among children ages 12 to 18, according to a study by the US Centers for Disease Control and Prevention. Vaccine effectiveness differed only slightly within that age group, with 91% effectiveness for children age 12 to 15 and 94% effectiveness for those age 16 to 18.

Continue Reading

Pfizer vaccine is 93% effective in preventing Covid-19 hospitalization among adolescents, CDC study finds

By Deidre McPhillips, CNN The Pfizer/BioNTech vaccine is 93% effective in preventing hospitalization due to Covid-19 among children ages 12 to 18, according to a study by the US Centers for Disease Control and Prevention. Vaccine effectiveness differed only slightly within that age group, with 91% effectiveness for children age 12 to 15 and 94%

Continue Reading